By WILL ASTOR
Rochester Business Journal
August 8, 2016
The Food and Drug Administration has given Vaccinex Inc.’s VX15 Huntington’s disease drug fast track status.
Huntington’s disease is a relatively rare affliction, affecting an estimated one in 10,000 individuals. Still, for sufferers and their families it amounts to a drawn out and increasingly unpleasant death sentence.